Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8836294rdf:typepubmed:Citationlld:pubmed
pubmed-article:8836294lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:8836294lifeskim:mentionsumls-concept:C0017082lld:lifeskim
pubmed-article:8836294lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:8836294lifeskim:mentionsumls-concept:C1521828lld:lifeskim
pubmed-article:8836294lifeskim:mentionsumls-concept:C1318444lld:lifeskim
pubmed-article:8836294lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:8836294pubmed:issue6lld:pubmed
pubmed-article:8836294pubmed:dateCreated1997-1-30lld:pubmed
pubmed-article:8836294pubmed:abstractTextIntratumoural administration of gangliosides (GSD) into a murine primitive neuro-ectodermal tumour, growing in the epicranial subcutaneous tissue of syngenic rats, results in a decrease in the tumour growth rate and causes a more differentiated phenotype of tumour cell, with immunohistochemical expression of neuronal markers. These findings suggest that the potential usefulness of intralesional administration of GSD for the control of tumours of primitive neuro-epithelial character could be considered.lld:pubmed
pubmed-article:8836294pubmed:languageenglld:pubmed
pubmed-article:8836294pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8836294pubmed:citationSubsetIMlld:pubmed
pubmed-article:8836294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8836294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8836294pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8836294pubmed:statusMEDLINElld:pubmed
pubmed-article:8836294pubmed:issn0001-6268lld:pubmed
pubmed-article:8836294pubmed:authorpubmed-author:OyaSSlld:pubmed
pubmed-article:8836294pubmed:authorpubmed-author:VaqueroJJlld:pubmed
pubmed-article:8836294pubmed:authorpubmed-author:CocoAAlld:pubmed
pubmed-article:8836294pubmed:authorpubmed-author:ZuritaMMlld:pubmed
pubmed-article:8836294pubmed:issnTypePrintlld:pubmed
pubmed-article:8836294pubmed:volume138lld:pubmed
pubmed-article:8836294pubmed:ownerNLMlld:pubmed
pubmed-article:8836294pubmed:authorsCompleteYlld:pubmed
pubmed-article:8836294pubmed:pagination759-62lld:pubmed
pubmed-article:8836294pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:8836294pubmed:meshHeadingpubmed-meshheading:8836294-...lld:pubmed
pubmed-article:8836294pubmed:meshHeadingpubmed-meshheading:8836294-...lld:pubmed
pubmed-article:8836294pubmed:meshHeadingpubmed-meshheading:8836294-...lld:pubmed
pubmed-article:8836294pubmed:meshHeadingpubmed-meshheading:8836294-...lld:pubmed
pubmed-article:8836294pubmed:meshHeadingpubmed-meshheading:8836294-...lld:pubmed
pubmed-article:8836294pubmed:meshHeadingpubmed-meshheading:8836294-...lld:pubmed
pubmed-article:8836294pubmed:meshHeadingpubmed-meshheading:8836294-...lld:pubmed
pubmed-article:8836294pubmed:meshHeadingpubmed-meshheading:8836294-...lld:pubmed
pubmed-article:8836294pubmed:meshHeadingpubmed-meshheading:8836294-...lld:pubmed
pubmed-article:8836294pubmed:meshHeadingpubmed-meshheading:8836294-...lld:pubmed
pubmed-article:8836294pubmed:meshHeadingpubmed-meshheading:8836294-...lld:pubmed
pubmed-article:8836294pubmed:meshHeadingpubmed-meshheading:8836294-...lld:pubmed
pubmed-article:8836294pubmed:meshHeadingpubmed-meshheading:8836294-...lld:pubmed
pubmed-article:8836294pubmed:meshHeadingpubmed-meshheading:8836294-...lld:pubmed
pubmed-article:8836294pubmed:meshHeadingpubmed-meshheading:8836294-...lld:pubmed
pubmed-article:8836294pubmed:year1996lld:pubmed
pubmed-article:8836294pubmed:articleTitleGangliosides modulate the growth rate and cell phenotype of a murine primitive neuro-ectodermal tumour.lld:pubmed
pubmed-article:8836294pubmed:affiliationNeurosurgical Department, Puerta de Hierro Clinic, Autonomous University, Complutensis University, Madrid, Spain.lld:pubmed
pubmed-article:8836294pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8836294pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed